T he sources of cells that form the different parts of the heart and their relationships to each other are of major fundamental interest for understanding cardiogenesis. They are also of biomedical significance in the context of congenital heart malformations and for future therapeutic approaches to cardiac malfunction based on stem cell therapies. In this review we mainly focus on myocardial cell lineages, with reference to the origin of the inner endocardial and outer epicardial cell layers of the heart. All these are derived from mesoderm. Neural crest cells, which play an important role in the maturation of the arterial pole of the heart are of neuroectodermal origin and under different genetic regulation, not treated here. We will discuss the current view emerging from a combination of approaches: cell lineage analyses that define the derivatives of a single mesodermal progenitor cell, cell labeling of groups of progenitors that reflects cell movement, and genetic tracing experiments based on the engineered temporal and spatial expression of a reporter gene in different cardiac progenitors and their descendants, with the mouse as the principal model system.
SOURCES OF CARDIAC CELLS IN THE EARLY EMBRYO
At the epiblast stage of embryonic development (about E6.5 in the mouse), the cardiac fate of individual cells labeled with horseradish peroxidase was determined and different cardiac progenitor cells were shown to be clonally related to paraxial mesoderm and extraembryonic mesoderm, as well as neurectoderm and endoderm (Lawson and Pedersen 1987; Buckingham et al. 1997) . These challenging experiments depended on embryo culture and did not permit analysis of cell contributions to the compartments of the maturing heart, mainly because of dilu-tion of the marker. More recent retrospective clonal analysis also indicated these early lineage relationships (Tzouanacou et al. 2009 ). Grafting of regions of the epiblast showed that progenitors for the endocardium and the pericardium are located in the same region as those for the myocardium (Tam et al. 1997) . These experiments also showed that cells are not committed to a cardiac fate at this stage, but will adopt the fate dictated by their location. This continues to be the case during gastrulation, when cells that will form the mesoderm ingress through the primitive streak. Fate mapping has shown that cardiac progenitors ingress early, at the midstreak stage, to become located in the anterior region of the primitive streak, which comprises newly forming mesoderm, in close proximity to progenitors of cranial (head) mesoderm (Kinder et al. 1999) . Distinct progenitors of the endocardium or myocardium have been identified in the primitive streak by retroviral labeling in the chick embryo (Wei and Mikawa 2000) , however, the timing of segregation of these cell types in the mouse remains controversial, as reviewed in Black 2010. Mesp1 (Saga et al. 1999 ) is expressed in the nascent mesoderm in the primitive streak, including cardiac progenitors, as well as in cells that will contribute to the anterior paraxial mesoderm. Genetic tracing with a Mesp1-Cre and Rosa26 conditional reporter shows that almost all cardiac cells in the heart are labeled, so that Mesp1 marks all cardiac progenitors (Fig. 1A,C) (Saga et al. 1999 Y Saga, unpubl.) .
Once cardiac progenitors have progressed through the streak they delaminate and move anteriorly to take up a position on either side of the midline under the head folds, at about E7.5 in the mouse embryo. It is at this stage that the first differentiated myocardial cells are detected in an epithelial crescent-shaped structure, which will subsequently fuse at the midline to form the early heart tube. Mesp1 may play a role in the delamination process, because it activates epithelio-mesenchymal transition (EMT) in the embryonic stem (ES) cell system, with genes like Snail, Twist1, Zeb1, and Zeb2 as downstream targets, that mediate the repression of E-cadherin expression (Bondue et al. 2008; Lindsley et al. 2008) . Although Mesp1 loss of function did not lead to an absence of cardiomyocyte differentiation during embryonic development, possibly owing to redundancy with Mesp2 , Mesp1 plays a key role as an upstream regulator of myocardial cell fate, as indicated by the major increase in cardiomyocyte differentiation following Mesp1 overexpression in ES cells (Bondue et al. 2008 (Bondue et al. , 2011 David et al. 2008; Lindsley et al. 2008 ). In the absence of Mesp1 and Mesp2, no mesodermal cells leave the primitive streak, demonstrating the essential role of Mesp1/2 in the delamination of cardiac mesoderm .
MYOCARDIAL CELL LINEAGES: REGIONALIZATION OF THE MYOCARDIUM Two Myocardial Cell Lineages that Segregate Early
Retrospective clonal analysis in the mouse embryo (see Buckingham and Meilhac 2011) indicated that two major lineages contribute to the myocardium of the heart. The first lineage contributes left ventricular myocardium, whereas the second lineage is the source of outflow tract and most right ventricular myocardium, with both lineages contributing to the atria and other parts of the heart ). The size of first or second lineage clones gives an indication of when segregation of the two lineages took place, leading to the conclusion that progenitors with these distinct contributions to the heart segregate early during embryonic development, probably at the onset of gastrulation. This genetic approach, which depends on a random recombination event that results in a functional reporter gene in cardiac progenitors and their progeny, does not involve any preconceived idea about the progenitor cell. In combination with DiI labeling to identify the left/ right derivatives of the posterior heart field, retrospective clonal analysis showed that right and left progenitors diverge before first and second heart lineages (Dominguez et al. 2012) . For precise information on the timing of segregation and also on the location of first and second lineage progenitors, it will be necessary to de-velop inducible genetic tools for clonal analysis (see Buckingham and Meilhac 2011) .
The cardiac crescent and early heart tube mainly contribute to the left ventricular myocardium (Zaffran et al. 2004 ). Tbx5 and HCN4 are early markers of the cardiac crescent and genetic tracing with an HCN4-Cre shows labeling of the embryonic left ventricle, mainly in the myocardial lineage (Fig. 1A) (Liang et al. 2013; Spater et al. 2013) . The concept of two myocardial cell lineages is complemented by the identification of a population of progenitor cells, described as the second heart field (SHF) that does not immediately differentiate into the myocardial cells of the cardiac crescent and newly formed heart tube. These progenitors are located medially to the cardiac crescent (first heart field) ( Fig. 2A) . Genetic tracing, explant experiments, and fluorescent dye labeling of cells, followed by embryo culture (Kelly et al. 2001; Zaffran et al. 2004; Galli et al. 2008) have shown the contribution of progenitor cells of the anterior and posterior regions of the SHF to the right ventricle (RV) and outflow tract at the arterial pole and to the atria at the venous pole of the heart, respectively. The SHF is marked by Isl1 expression and genetic tracing with Isl1-Cre showed labeling typical of the second lineage contribution (Cai et al. 2003) .
More recently, with new Isl1-Cre lines and more sensitive reporters more extensive labeling of the heart has been observed (Sun et al. 2007; Ma et al. 2008) . However, deletion of Isl1 leads to a phenotype that corresponds to a defect of the second lineage where the morphogenesis of the arterial and venous poles of the heart is affected (Cai et al. 2003) .
The early segregation of the two lineages suggests that progenitors of the SHF are distinct from those that form the cardiac crescent and early cardiac tube. In the chick embryo, cells that will contribute to the outflow tract are located more anteriorly in the cardiogenic region of the primitive streak (Garcia-Martinez and Schoenwolf 1993; Abu-Issa and Kirby 2007). Regionalization of the heart. (A) First (red) and second (green) heart fields and anterior ( pale green/ yellow) or posterior (dark green) subdomains of the second heart field are shown at different stages of heart and head development. Regions of the heart with a dual origin are shown with colored dots. (B) Left (dark blue)/ right ( pale blue) derivatives of the second heart field, also showing right and left facial expression muscles in the head. Stages are as in A. ao, aorta; iAVC, inferior atrioventricular canal; sAVC, superior atrioventricular canal; E, embryonic day; LA, left atrium; dLA, dorsal left atrium; dLCA, dorsal left common atrium; vLCA, ventral left common atrium; LSCV, left superior caval vein; LV, left ventricle; OFT, outflow tract; PhA, pharyngeal arches; pt, pulmonary trunk; PV, pulmonary vein; RA, right atrium; RCA, right common atrium; RSCV, right superior caval vein; RV, right ventricle.
Furthermore, in vivo imaging in the quail embryo, showed that labeled cardiac progenitors move together as coherent groups of cells as they leave the primitive streak, but change their relative anterior/posterior position to a medial/lateral juxtaposition as a result of endoderm folding that produces morphological changes in the overlying mesoderm (Cui et al. 2009 ). This is consistent with the more subsequent medial location of radioactive grafts from the anterior cardiogenic region of the primitive streak (Rosenquist 1970) . Early expression of Mesp1 in cardiac progenitors in the primitive streak provides a genetic marker in the mouse embryo that can potentially distinguish progenitor populations based on genetic tracing. During ES cell differentiation, Mesp1-expressing cells can give rise, at a single cell level, to colonies expressing both Tbx5 and Isl1 suggesting that Mesp1-expressing cells might correspond to common progenitors for both the first and SHFs (Bondue et al. 2011) . Prospective clonal analysis using inducible Cre expression in Mesp1-expressing cells will be necessary to investigate whether these cells mark common progenitors for both heart fields in vivo.
Sublineages of the Second Myocardial Cell Lineage that Contribute to the Arterial Pole of the Heart
The initial identification of the anterior SHF was possible owing to the preferential expression of an Fgf10-LacZ reporter transgene, which marks cells that will form the RVand the outflow tract (Kelly et al. 2001) . Other genes such as Fgf8 and Tbx1 are also expressed preferentially in the anterior part of the SHF, which is also marked by the activity of a specific Mef2C enhancer sequence Dodou et al. 2004; Xu et al. 2004) . Combined loss of function of Fgf8/10 resulted in defects of the RVand outflow tract (OFT) (e.g., Watanabe et al. 2010) , consistent with the contribution of these progenitors to the arterial pole of the heart. Loss of function of Tbx1 affects myocardium at the base of the pulmonary trunk (Theveniau-Ruissy et al. 2008) . DiGeorge syndrome patients, with deletions of a region of chromosome 21 where TBX1 is located, have tetralogy of Fallot, with overriding aorta, a ventricular septal defect, and right ventricular hyperplasia, thought to be secondary effects of underdevelopment of pulmonary trunk myocardium (Van Praagh 2009) .
In addition to the RV and OFT, the arterial pole of the heart is associated with the formation of noncardiac muscles. Genetic tracing experiments have shown that genes such as Mesp1, Nkx2.5, or Isl1 are expressed in progenitor cells that also give rise to a subset of skeletal muscles of the head (Nathan et al. 2008; Harel et al. 2009 ), which unlike muscles of the trunk and limbs, do not derive from paraxial mesoderm of the somites and are regulated by distinct transcription factors, acting upstream of the myogenic determinants. These progenitors are also marked by the activity of the anterior SHF Mef2c enhancer sequence (Lescroart et al. 2010) . Masticatory and facial expression muscles derive from the first and second pharyngeal (or branchial) arches, respectively (Noden and Francis-West 2006) . The branchial arches (1,2,3,5,6) are transient structures that protrude from the pharynx and contain pharyngeal mesoderm that can be regarded as an extension of the SHF, where SHF marker genes such as Fgf10 (Kelly et al. 2001) , Isl1 (Cai et al. 2003) , and Tbx1 ) are expressed. Myogenic and myocardial progenitor cells are present in the mesodermal core of the first two arches where they begin to segregate, as evidenced by expression of the myogenic determinants MyoD and Myf5 in the more proximal region, whereas SHF markers, such as Isl1, continue to be expressed in cardiac progenitors more distally (Tirosh-Finkel et al. 2006; Nathan et al. 2008) . Retrospective clonal analysis (Lescroart et al. 2010) shows that common progenitors give rise to head muscles and to myocardium at the arterial pole of the heart, providing a lineage tree (Fig. 3 ) in which more anterior head muscles such as the masseter and temporalis, derived from the first pharyngeal arch, are more closely related to the RV, whereas facial expression muscles derived from the second pharyngeal arch are more closely related to OFT myocardium. Left/right lineage segregation is also observed between cardiac and extra-cardiac derivatives, distinguishing left facial expression muscles and pulmonary trunk myocardium from right facial expression muscles and the myocardium at the base of the aorta (Lescroart et al. 2010) . Altogether, these studies indicate that the SHF can be divided into subdomains that contribute to the different regions of the arterial pole of the heart, as well as to facial muscles of the head.
The SHF also gives rise to endothelial cells that form the arterial tree at the outflow region of the heart, as illustrated by genetic tracing experiments using Isl1-Cre and anterior SHF Mef2c enhancer-Cre (Verzi et al. 2005; Sun et al. 2007 ). Mutation of Fgf8/10 ( Watanabe et al. 2010) or Tbx1 in the SHF leads to abnormal development of arteries derived from this pharyngeal mesoderm.
Smooth muscle cells, which surround the great vessels at the arterial pole, also arise from the SHF as shown by dye labeling in the chick embryo (Waldo et al. 2005; Ward et al. 2005) , with the suggestion that SHF progenitors can be bipotent, such that smooth muscle shares a common progenitor with the myocardium (Hutson et al. 2010 ). The differentiation potential of cardiac progenitors at the clonal level has been essentially assessed using in vitro differentiation. During ES cell differentiation, Isl1-expressing cardiac progenitors can give rise to myocardial, endothelial, and smooth muscle cells (Moretti et al. 2006) , supporting the notion that SHF cells can be multipotent (Fig. 1B) . However, although lineage tracing at the population level labeled cardiomyocytes, endothelial cells, and smooth muscle cells (Cai et al. 2003; Sun et al. 2007; Ma et al. 2008) , there is no evidence so far that such multipotent SHF progenitors exist in vivo. Furthermore, the intrinsic and extrinsic cues leading to the differentiation of the SHF into a particular fate remain largely unexplored.
From a medical perspective, it is possible that diseases that lead to a defect in the arterial pole of the heart may be accompanied by abnormalities of the skeletal muscles of the head, smooth muscle, and endothelial cells, and arise from a defect in a common progenitor of the cardiomyocytes of the SHF and other derivatives.
Sublineages that Contribute to the Venous Pole of the Heart
The second myocardial cell lineage also contributes to the atria and this is reflected in the ad- dition of cells to the forming heart tube from the posterior part of the SHF, as shown by fluorescent dye labeling (Galli et al. 2008 ). This posterior region is characterized by Isl1 expression, without expression of anterior SHF markers such as Fgf8/10 or Tbx1. Explant experiments show that these cells have atrial potential, with left/right commitment revealed by transgenic markers (Galli et al. 2008) .
As development proceeds, the sinus venosus forms, giving rise to caval vein myocardium. Tbx18 is expressed in this myocardium. The earlier lateral expression of Tbx18 may mark a progenitor pool that gives rise to both caval vein myocardium and the proepicardial organ (PEO), which then segregate following exposure to bone morphogenetic protein (BMP) or fibroblast growth factor (FGF) signaling, respectively, as suggested by experiments in the chick embryo (van Wijk et al. 2009 ). Surprisingly, the caval vein progenitors in the posterior SHF do not express Isl1 or Nkx2-5, unlike those of the rest of the heart. These distinct properties led to the proposition that the Tbx18-positive progenitors of caval vein myocardium constitute a distinct third heart field Mommersteeg et al. 2010) . Similarly, in the chick a population of cells that is negative for both Isl1 and Nkx2.5 expression and contributes to the development of the sinoatrial node, located in the right superior caval vein, was also suggested to constitute a third heart field (Bressan et al. 2013) . Dye labeling of these progenitors in the chick embryo also shows labeled cells in the atria. However, retrospective clonal analysis in the mouse (Lescroart et al. 2012) shows that caval vein myocardium, which includes the sinoatrial node, is not a distinct myocardial cell lineage but rather a sublineage of the SHF. Right caval vein myocardium is closely related to right atrial myocardium, whereas myocardium of the left caval vein forms a sublineage with left atrial myocardium. In both cases the clonal relationship is particularly pronounced for the dorsal region of the atria. Pulmonary vein myocardium also belongs to the left sublineage. Different modes of clonal growth within this myocardium would be consistent with a dual origin for the pulmonary vein from left atrial outgrowth and from addition of cells from the SHF (Lescroart et al. 2012 ). Interestingly, Wnt2-Cre genetic tracing also marked a posterior subdomain of the SHF that derives from progenitor cells expressing Isl1 and Gli1. Genetic tracing, using Wnt2-CreERT2 induced at E8.5 and a ROSA26 reporter, labeled cells of the sinus venosus and later myocardial cells of the pulmonary vein as well as smooth muscle and endothelial cells of the pulmonary artery (Peng et al. 2013) , suggesting that the contribution of this posterior domain of the SHF might be broader than previously thought and might include a population of multipotent cardiopulmonary progenitors.
Surprisingly, this analysis of lineages at the venous pole also revealed a clonal relationship between the left venous pole and pulmonary trunk myocardium, which forms from the anterior SHF. Because myocardium of the outflow region of the heart is derived exclusively from the second lineage, this is consistent with the second lineage origin of the venous pole. Detailed cell fate mapping, based on fluorescent dye labeling followed by embryo culture, also showed that a subset of cells in the posterior SHF contribute to outflow tract myocardium (Dominguez et al. 2012 ), suggesting significant cell migration within the SHF Bajolle et al. 2008 ). The fate-mapping approach also showed an additional contribution of the posterior SHF to the atrioventricular canal, supported by clonal analysis . The derivatives of left/right regions of the posterior heart field were identified as the superior atrioventricular and the inferior atrioventricular canal, respectively (Fig. 2B) (Dominguez et al. 2012) .
The pulmonary trunk myocardium is clonally related to the left venous pole, but this is distinct from the sublineage that contains common progenitors with left facial expression muscles. Pulmonary trunk myocardium therefore derives from two sources: the anterior and the posterior SHF. Given the congenital malformations affecting pulmonary trunk myocardium, it will be important in the future to distinguish between the cellular origins of these defects. Those that are owing to abnormal con-tributions from the posterior SHF sublineage are likely to be associated with venous pole defects. In general, arterial pole malformations are the most frequent form of congenital heart malformation and can frequently be corrected surgically (Gelb et al. 2013 ). More subtle venous pole defects are not so evident. In a certain number of cases, in which arterial pole surgery did not result in the improvement of heart function, venous pole abnormalities were subsequently identified (Bajolle et al. 2009 ). It is thus important to check for these rarer defects at the time of arterial pole surgery because some venous pole defects can also be corrected surgically.
MYOCARDIAL LINEAGES IN THE MATURING HEART
The Interventricular Septum
As the heart matures, an interventricular septum forms. This outgrowth of myocardium is marked by transgenes expressed in left or right ventricular myocardium, with a spatial distribution of labeled cells that suggests a more extensive left ventricular contribution to the dorsal part of the septum. The extension of clones into the septum from left or right ventricular myocardium also points to a dual origin (Franco et al. 2006 ). This might suggest that both first and second lineages contribute to the ventricular septum. It is possible that not all precursor cells of the first lineage differentiate at the crescent stage, but that some first lineage cells are still present in the SHF. It is also possible that some right ventricular cells relocate to the left ventricular compartment. A wider contribution of cells initially restricted to a specific subdomain is also seen in genetic tracing with a Tbx1-Cre, which initially labels cells only in the outflow region but subsequently marks cells in a central domain of the RV, which extends into the interventricular septum ).
Compact and Trabeculated Myocardium
In the heart tube, the walls of the chambers thicken in a process referred to as trabeculation. This is regulated by signals from the endocardium and epicardium, via Notch and Neuregulin (Grego-Bessa et al. 2007) or retinoic acid and FGF (Merki et al. 2005; Peshkovsky et al. 2011) signaling cascades, respectively. By E12.5 in the mouse heart, the outer cardiomyocytes that will constitute the compact layer begin to express distinct marker genes, including Tbx20, Hey2, or Mycn, not expressed by the inner layer of cardiomyocytes that will form the trabeculae, characterized by expression of genes such as Nppa, Cx40, cdkn1c, or Bmp10 (Moens et al. 1993; Delorme et al. 1997; Kochilas et al. 1999; Nakagawa et al. 1999; Neuhaus et al. 1999; Christoffels et al. 2000; Stennard et al. 2003) . These different types of cardiomyocytes are clonally related, as suggested by retrospective clonal analysis. Clones grow with a wedge shape from the compact to the trabeculated layer (Meilhac et al. 2003) , which corresponds to decreased proliferation in the trabeculae (Mikawa et al. 1992; Sedmera et al. 2003) , compared with the compact layer, which proliferates in response to mitogenic signals from the epicardium (Sucov et al. 2009 ). Although in zebrafish (Gupta and Poss 2012) , one trabeculum arises from the differentiation of multiple cardiac progenitors, it is still not clear whether the polyclonality of the trabeculum is conserved across vertebrates. Recent results on zebrafish have thrown new light on the formation of trabeculae by cardiomyocyte delamination (Staudt et al. 2014 ).
The Cardiac Conduction System
The cardiac conduction system generates and transmits electrical impulses that coordinate and regulate contractions of the heart. The origin of the conduction system has been controversial. Based on the expression of some neural crest markers it had been initially proposed that in mammals it derived from neural crest cells (Gorza et al. 1988) . However, at least 80% of the ventricular conduction system derives from cardiac mesoderm, as shown by genetic tracing with a Mesp1-Cre (Kitajima et al. 2006) . The absence of labeling of 20% of these cells can potentially be explained by an incomplete recombination of the reporter line (Miquerol et al. 2013; L Miquerol, unpubl.) 
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derive from a different source. In the chick embryo, ventricular conduction system cells were thought to arise from a distinct population of cells located at the top of the interventricular septum (Lamers et al. 1991; Chan-Thomas et al. 1993) or by recruitment of neighboring cardiomyocytes (Gourdie et al. 1998 ). Retrospective clonal analysis in the mouse embryo supports the first hypothesis, showing that the central conduction system, including the atrioventricular node and His bundle, segregate early from the precursors of the working myocardium (Miquerol et al. 2013 ). Expression of Tbx3, which marks the central conduction system, is first seen at the early heart tube stage (Hoogaars et al. 2004 ), although it is still not proven that these Tbx3-positive cardiomyocytes are conductive progenitors. Recently, in the chick, precursors of the pacemaker cells of the sinoatrial node have been mapped in the mesoderm caudal to the Nkx2-5, Isl1-expressing SHF. Canonical Wnt signaling promotes the specification of these pacemaker cells, whereas it inhibits differentiation into contractile cardiomyocytes (Bressan et al. 2013) . However, in the mouse, the sinoatrial node was shown to derive mainly from Isl1-and Tbx18-expressing progenitors (Liang et al. 2013) , suggesting an SHF origin (see sections on sublineages). In contrast to the central conduction system, the peripheral conduction system shares common ventricular progenitors for contractile and conductive cardiomyocytes until E16.5 (Miquerol et al. 2010) . After segregation, cells of both lineages continue to proliferate, although to a lesser extent for the conductive cardiomyocytes. The peripheral conduction system has a dual origin that reflects the distinct origins of the ventricles, such that the RV and right Purkinje fiber network are clonally distinct from the left bundle branch of the conduction system and the left ventricle (Miquerol et al. 2013) . By genetic tracing, these two populations can be distinguished based on the expression of Isl1 or HCN4 and Nkx2-5, respectively, in the precursors (Liang et al. 2013 ).
At present, the possible nonmyocardial sources of the mammalian conduction system are still poorly understood. This information is potentially important for diagnosis and prognosis of certain types of cardiac arrhythmias, which are a frequent human health problem. The successful generation of biological pacemakers for therapeutic purposes from ES or induced pluripotent stem (iPS) cells, for example, would also benefit from knowledge of the origins of different parts of the conduction system.
ENDOCARDIUM
The endocardium is the inner surface of the heart and is composed of endothelial cells. Genetic tracing that leads to the labeling of the myocardium (Nkx2-5-Cre, Isl1-Cre, as well as with the anterior SHF Mef2C-enhancer-Cre) also results in the labeling of the endocardium (Stanley et al. 2002; Cai et al. 2003; Verzi et al. 2005; Sun et al. 2007; Ma et al. 2008) , indicating that these two lineages share spatial and molecular characteristics. In the absence of clonal analysis, it is not clear whether cardiac progenitors are truly bipotent (Linask et al. 1997) , but the role of Etv2 might indicate that this is the case. Nkx2-5 is required for the activation of Etv2 (Ferdous et al. 2009 ), which encodes a transcription factor that is essential for the specification of endocardial cells (De Val et al. 2008 ). In the absence of Etv2, the cells that should have expressed it differentiate into other muscle lineages including myocardium (Rasmussen et al. 2011) . In vitro differentiation of early (Brachyury-GFP
þ ) cardiac progenitors, isolated from mouse embryos or during ES cell differentiation, can give rise to cells expressing endocardial/endothelial markers as well as myocardial markers, suggesting that at both stages these cells correspond to progenitors for both the endocardium and myocardium (Fig. 1B) (Kattman et al. 2006; Moretti et al. 2006) . Indeed, using Nfatc1 expression as a marker that distinguishes endocardium from other endothelial cells, it was proposed that during ES cell differentiation, multipotent Flk1-positive cardiac progenitors can differentiate into both myocardial and endocardial cells in vitro (Misfeldt et al. 2009 ). It is not clear when the myocardial and the endocardial lineages segregate during cardiovascular development. However, by the time myocardial cells begin to express the first contractile protein genes as the cardiac crescent beginsto form, small clusters of more ventrally located endocardial cells can be distinguished (Kaufman and Navaratnam 1981) . Cell lineage analyses at the clonal level, with temporal control and a reporter expressed in both cell types, would be essential to establish the existence of a common progenitor for endocardium and myocardium and to determine the time of segregation of these two lineages.
EPICARDIUM
The epicardium derives from the PEO, a transient group of cells adjacent to the venous pole of the heart, between E8.5 and E10.5 (Schulte et al. 2007 ). It probably forms from the splanchnic mesoderm of the septum transversum that later gives rise to the diaphragm (Viragh and Challice 1981) . The PEO and its derivatives are marked by Isl1-Cre genetic tracing (Moretti et al. 2006; Sun et al. 2007; Zhou et al. 2008b) , suggesting a close relationship with other cardiac progenitors. Nkx2-5-Cre tracing also labels these cells, and in contrast to Isl1, Nkx2-5 is required for PEO formation (Zhou et al. 2008b) . The PEO and the epicardium are marked by the expression of Tbx18 and Wt1 (Fig. 1A) . Tbx18 is first expressed in anterior lateral mesoderm on either side of the area where Isl1-positive myocardial progenitors are present (Kraus et al. 2001; Mommersteeg et al. 2010) . Expression of Cited2, which marks the septum transversum (Dunwoodie et al. 1998) , suggests that cells forming this structure may arise initially from a more anterior domain. At the time of foregut closure, morphogenetic changes result in the movement of this anterior territory to a more posterior position at the venous pole of the heart, where the PEO is in close proximity to progenitors of inflow tract myocardium (van Wijk et al. 2009 ), some of which also express Tbx18 . Later, cells of the PEO cover the surface of the heart to form the epicardium. Subsequently, cells delaminate from the epicardium, undergoing Wt1/ Snail-dependent EMT (Martinez-Estrada et al. 2010) and enter the myocardium where they constitute the interstitial fibroblast population of the heart and also contribute to the coronary vasculature. A recent study challenged the notion that the endothelial cells of the coronary vasculature derive from the PEO, as these vessels were labeled with a VE-cadherin-CreER line induced at E7.5, which did not label the PEO, indicating that endothelial cells of the coronary veins come from the venous plexus at the sinus venosus (Red-Horse et al. 2010) . In contrast, the endothelium of coronary arteries derives from the endocardium, as shown by genetic tracing with an inducible Nfatc1-CreErt2 (Wu et al. 2012) . The myocardial potential of the epicardium has been controversial. PEO-derived cells, when manipulated with growth factors in culture, can give rise to myocardial cells (Kruithof et al. 2006; van Wijk et al. 2009 ). Although classic fate-mapping studies in chick and mouse did not show that the PEO contributes to myocardium in vivo (Winter and Gittenberger-de Groot 2007) , more recent genetic tracing experiments with a Wt1-Cre (Zhou et al. 2008a) or Tbx18-Cre ) result in the labeling of some myocardial cells. However, the interpretation of these experiments has been questioned (Christoffels et al. 2009 ), as Tbx18 can be expressed by some cardiomyocytes and Wt1 is expressed earlier in the primitive streak, complicating the lineage interpretation of these genetic tracing studies. Nevertheless, in these experiments cultured labeled epicardium can result in labeled cardiomyocytes, again indicating the myocardial differentiation potential of epicardial cells. Furthermore, myocardial cells can be generated from cells isolated from the coronary vasculature (Galvez et al. 2008 ) and after manipulation of cardiac fibroblasts (Qian et al. 2012) . The myocardial regenerative potential of the epicardium and its derivatives is a focus of therapeutic interest for cardiomyocyte regeneration in heart failure.
CONCLUSION
Knowledge about the origins and interrelationships of cells that form the heart is of fundamen-Cite this article as Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a013888
tal importance for our understanding of cardiogenesis. It is also very important for the diagnosis and treatment of heart malformations. This is illustrated by the observation that myocardial cells in the pulmonary trunk derive from the same progenitor cells as myocardial cells of the left venous pole, so that malformations of the arterial pole may be associated with more subtle malformations of the venous pole. Detection of such malformations means that it may also be possible to correct them surgically at birth to save the life of the child. The fact that the pulmonary trunk myocardium comes from two distinct sources also has clinical implications for heart disease. The development of therapeutic approaches for the failing heart depends on insights from cardiogenesis. This is particularly true for stem cell-based therapies.
The relationships between other cell types of the heart, such as fibroblasts or epicardial cells, and the myocardium underlie attempts to capitalize on the myocardial potential of these cells for cardiac regeneration. Lineage relationships between different compartments of the heart are also of significance in deriving myocardial cells of the appropriate type from iPS or ES cells, before introducing them into the failing heart. Studies of cell lineage and of the function of genes that mark different cardiac progenitor cell populations have opened new perspectives for diagnosis and treatment. Further understanding of myocardial cell behavior, such as proliferation potential, as well as of the mechanisms that define different cardiac progenitors, will continue to impact cardiology. 
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